Nano-Drug Delivery Systems Based on Different Targeting Mechanisms in the Targeted Therapy of Colorectal Cancer

Molecules. 2022 May 6;27(9):2981. doi: 10.3390/molecules27092981.

Abstract

Colorectal cancer (CRC) is a usual digestive tract malignancy and the third main cause of cancer death around the world, with a high occurrence rate and mortality rate. Conventional therapies for CRC have certain side effects and restrictions. However, the exciting thing is that with the rapid development of nanotechnology, nanoparticles have gradually become more valuable drug delivery systems than traditional therapies because of their capacity to control drug release and target CRC. This also promotes the application of nano-drug targeted delivery systems in the therapy of CRC. Moreover, to make nanoparticles have a better colon targeting effect, many approaches have been used, including nanoparticles targeting CRC and in response to environmental signals. In this review, we focus on various targeting mechanisms of CRC-targeted nanoparticles and their latest research progress in the last three years, hoping to give researchers some inspiration on the design of CRC-targeted nanoparticles.

Keywords: colorectal cancer; drug delivery systems; nanoparticles; targeted therapy.

Publication types

  • Review

MeSH terms

  • Colorectal Neoplasms* / drug therapy
  • Drug Delivery Systems
  • Humans
  • Nanoparticle Drug Delivery System
  • Nanoparticles* / therapeutic use
  • Nanotechnology

Substances

  • Nanoparticle Drug Delivery System